Association of Obesity to The Prevalence and Severity of Gastroesophageal Reflux Disease (GERD) : A Systematic Review
Abstract
Introduction: Gastroesophageal Reflux Disease (GERD) and obesity are two escalating global health crises with a well-documented association. While the link is known, a comprehensive synthesis of how different measures of obesity impact both the prevalence and objective severity of GERD is needed. This systematic review aims to evaluate and synthesize the current evidence on the association between obesity and the prevalence and severity of GERD.
Methods: Following PRISMA guidelines, a systematic search was conducted across PubMed, Springer, Semantic Scholar, Google Scholar, and Wiley Online Library. We included observational studies and meta-analyses from the last ten years that examined the relationship between obesity (measured by BMI, waist circumference, etc.) and GERD (diagnosed via validated questionnaires, endoscopy, or pH monitoring) in adult populations. Twenty studies met the eligibility criteria and were included in the final analysis.
Results: All 20 included studies reported a positive association between increased body mass and GERD risk or severity. Meta-analyses reported significant odds ratios for GERD in obese individuals, ranging from 1.73 to 4.25. A clear dose-response relationship was evident, with risk increasing with BMI category. Notably, central and visceral obesity were identified as particularly strong predictors of severe erosive esophagitis, sometimes more so than general BMI. Physiologically, obesity was linked to increased esophageal acid…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.